Logo Unión Europea

INLUNG: New drug candidates for non-small cell lung cancer treatment

R&D Project INLUNG

New drug candidates for non-small cell lung cancer treatment: lead optimisation and development of CTP inhibitors

Consortium: Alchemy and GalChimia

Within the framework of the 2018 INNOGLOBAL programme, the Centre for Industrial Technological Development (CDTI) has awarded funding for the project INLUNG. Its objective is to develop new drugs for the treatment of non-small cell lung cancer (NSCLC).

The project has a budget of €234,418.00 and is funded by the CDTI under the Spanish National Programme for Business Leadership in R&D, within the framework of the Spanish National Plan for Scientific and Technical Research and Innovation 2017–2020, and supported by the Spanish Ministry of Economy, Industry and Competitiveness.


GalChimia thanks all the partners in the INLUNG project for their involvement and teamwork, which have been key to the success of the project.

Logo Galchimia letters

Subscribe to stay updated on the latest advances in organic synthesis and GalChimia’s good chemistry

     "*" mandatory

    I agree, and accept the data protection policy